BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10091979)

  • 1. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.
    Spector JG; Sessions DG; Chao KS; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Mar; 21(2):116-23. PubMed ID: 10091979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
    Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time.
    Hoekstra CJ; Levendag PC; van Putten WL
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):13-21. PubMed ID: 2298616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
    Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
    Shimm DS; Coulthard SW
    Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.
    Turesson I; Sandberg N; Mercke C; Johansson KA; Sandin I; Wallgren A
    Acta Oncol; 1991; 30(3):357-62. PubMed ID: 2036247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].
    Zhang Q; Lai FY; Guo ZM; Zeng ZY; Song M; Yu WB; Yang CS
    Ai Zheng; 2007 Oct; 26(10):1138-42. PubMed ID: 17927888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
    Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
    Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early glottic cancer: the influence of primary treatment on voice preservation.
    Lesnicar H; Smid L; Zakotnik B
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1025-32. PubMed ID: 8985023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
    McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
    Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1-2 glottic cancer treated with radiotherapy and/or surgery.
    Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
    Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.